Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India

Detalles Bibliográficos
Autores principales: Varshney, Amit, Rawat, Ramakant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427181/
https://www.ncbi.nlm.nih.gov/pubmed/37585983
http://dx.doi.org/10.1590/1806-9282.20230090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427181/
https://www.ncbi.nlm.nih.gov/pubmed/37585983
http://dx.doi.org/10.1590/1806-9282.20230090

Ejemplares similares